This Week in Aesthetics: July 20-24

This week in aesthetics, Endo Aesthetics announce the FDA approval of injectable QWO for cellulite treatment, legal experts and physicians discuss liability during COVID-19, and we highlight threadlifts as “injectables.” In our summer print issue, “Uncharted Territory,” Dr. Randolph Waldman reflects on practicing during the pandemic, and Dr. Annalisa Calisti shares the story of two Iraqi female physicians who have created access for women to medicine and cosmetic surgery.

FDA Approves QWO for Cellulite Treatment

Endo Aesthetics announced the U.S. FDA approval of QWO for the first and only injectable treatment of moderate to severe cellulite of the buttocks in adult women

Avoiding Legal Landmines During COVID-19

In May, we convened a panel of legal experts and respected physicians to discuss the legal landscape facing the private practice during COVID-19, including strategies for minimizing liability risk. Overwhelmingly, the panel agreed on several key points for avoiding legal landmines

Threads as ‘Injectables’

It's a paradigm shift for the threadlift, which offers subtle tissue adjustment and biostimulation to generate natural results that last beyond the life of the threads themselves

Uncharted Territory: Aesthetic Authority Vol.1: No.2

The Summer issue of Aesthetic Authority offers cutting-edge treatment- and trend-related content, while also confronting current challenges affecting the specialty

‘Here Comes the Sun’

In his latest editorial, Dr. Randolph Waldman reflects on practicing aesthetic medicine during the pandemic and paints a picture of hope for where the specialty goes from here

The Roses of Baghdad

From pandemic concerns to cultural limitations, aesthetic physician Dr. Annalisa Calisti shares the story of two Iraqi female physicians who have created access for women to medicine and cosmetic surgery, all while respecting tradition.